Your browser doesn't support javascript.
loading
Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice-weekly carfilzomib (45 and 56 mg/m2 ) in combination with lenalidomide and dexamethasone.
Korde, Neha; Mastey, Donna; Tavitian, Elizabet; Mailankody, Sham; Lesokhin, Alexander; Hassoun, Hani; Smith, Eric L; Lendvai, Nikoletta; Hultcrantz, Malin; Shah, Urvi; Tan, Carlyn; Lu, Sydney; Diamond, Benjamin; Salcedo, Meghan; Werner, Kelly; Chung, David J; Scordo, Michael; Shah, Gunjan L; Lahoud, Oscar; Landau, Heather; Arcila, Maria; Ho, Caleb; Roshal, Mikhail; Dogan, Ahmet; Derkach, Andriy; Devlin, Sean M; Giralt, Sergio A; Landgren, Ola.
Affiliation
  • Korde N; Multiple Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Mastey D; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
  • Tavitian E; Multiple Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Mailankody S; Multiple Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Lesokhin A; Multiple Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Hassoun H; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
  • Smith EL; Multiple Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Lendvai N; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
  • Hultcrantz M; Multiple Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Shah U; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
  • Tan C; Medical Oncology, Dana-Farber Cancer Institute, New York, New York, USA.
  • Lu S; Multiple Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Diamond B; Multiple Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Salcedo M; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
  • Werner K; Multiple Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Chung DJ; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
  • Scordo M; Multiple Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Shah GL; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
  • Lahoud O; Multiple Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Landau H; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
  • Arcila M; Multiple Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Ho C; Multiple Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Roshal M; Multiple Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Dogan A; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
  • Derkach A; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Devlin SM; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
  • Giralt SA; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Landgren O; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
Am J Hematol ; 96(6): E193-E196, 2021 06 01.
Article in En | MEDLINE | ID: mdl-33661527
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Multiple Myeloma Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Multiple Myeloma Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2021 Type: Article